article thumbnail

Magnolia Regional used price transparency IT to get more CHF patients to fill their prescriptions

Healthcare It News

"With prescription drug prices rising at every turn, patients need price transparency and the ability to discuss options with their doctors during office visits," Davis advised. ADVICE FOR OTHERS.

article thumbnail

The Health Insurance Premium for a Family Averages $25,572 in 2024 – KFF’s Annual Update on Employer-Sponsored Benefits

Health Populi

The premium for employer-sponsored health plans grew by 6-7% between 2023 and 2024, according to the report on Employer Health Benefits 2024 Annual Survey from the Kaiser Family Foundation, KFF’s 26th annual study into U.S. In 2024, 54% of all firms offered some health benefits, stable with 2023’s offer rate.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

HIT Consultant

What You Should Know: – CVS Health today hosted its 2023 Investor Day, where the company outlined its strategy for driving reliable, diversified, and accelerating earnings growth while delivering superior care and value to millions of Americans.

article thumbnail

Medication Safety & Affordability Improving According to Surescripts Data

Healthcare IT Today

Real-time Prescription Benefit High prescription drug prices create affordability challenges for patients and the health care system as a whole.

article thumbnail

Comments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 2023

Health Law Advisor

This feedback must be submitted to CMS by March 11, 2023 via email ( IRARebateandNegotiation@cms.hhs.gov ). Manufacturers reportedly met with CMS on February 27, 2023, after the release of the Initial Inflation Rebate Guidances, to provide additional feedback on the rebate program.

article thumbnail

A Health Consumer Bill of Rights: Assuring Affordability, Access, Autonomy, and Equity

Jane Sarashon

In addition to highlighting the Patient’s Bill of Rights, NABIP’s keynotes and general sessions will speak to similar topics being brainstormed at VIVE this week — including mental health, maternal health, pharmacy and prescription drugs (pricing, PBMs), population health, and Medicare and Medicaid innovations.

ACA 118
article thumbnail

The Cost of Treating Patients is On the Rise: PwC Goes What’s Behind the 2024 Medical Spending Numbers

Health Populi

Take prescription drugs pushing medical trend upward. At the same time, the countervailing pressure on Rx prices downward come from the growth of biosimilar products coming on-stream, priced on average 50% lower than the reference price of products at the time of the launch for the biosimilar.